Drug Discovery

56 summarised stories about Drug Discovery, each linking back to the original source. Browse all topics →

+ Follow this topic

Key players

OpenAI Anthropic Co-Scientist Co-Scientist Google DeepMind Isomorphic Labs

Thursday, 16 April 2026

Introducing GPT-Rosalind for life sciences research

OpenAI 6 months ago 8

OpenAI released GPT-Rosalind, a reasoning model designed to assist with drug discovery, genomics analysis, and protein research tasks. The model applies advanced reasoning capabilities to scientific workflows that typically require extensive computational analysis and expert interpretation. Researchers in life sciences can now use GPT-Rosalind to process complex biological data more efficiently than previous general-purpose AI systems.

Read the full story

Drug Discovery

The daily briefing

Every AI story that matters,
in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.

TLDRocket 17 October 2026

AI governance moved from slideware to the boring-but-important mechanics of who gets to fetch, act, and prove. Meta quietly rewrote parts of its commercial terms, removing wording that appeared to let it use web content to “train” and “maintain the integrity” of its products; the update followed legal scrutiny that it could be read as broad scraping permission. At the same time, users reported that major websites are blocking AI agents from completing tasks across services—turning “agentic” demos into something closer to permissioned automation. ServiceNow is now trying to sell the glue for that reality with its AI Control Tower, positioning it as an enterprise platform to discover and govern agents across models and clouds, while a field study of 15 large-enterprise customers questioned how fully its runtime enforcement and AI lifecycle evidence hold up versus alternatives.

Read the full briefing →

Drug Discovery

Key players

Thursday, 16 April 2026

Introducing GPT-Rosalind for life sciences research

Every AI story that matters, in your inbox by 8am.

Every AI story that matters,
in your inbox by 8am.